Sciencast Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$511K Sell
21,230
-182,029
-90% -$4.76M 0.11% 187
2026
Q1
$5.71M Buy
203,259
+187,259
+1,170% +$4.99M 0.73% 66
2025
Q4
$398K Buy
+16,000
New +$403K 0.06% 231
2025
Q1
Sell
-52,277
Closed -$1.39M 331
2024
Q4
$1.39M Buy
+52,277
New +$1.42M 0.38% 117
2024
Q2
Sell
-46,648
Closed -$1.29M 325
2024
Q1
$1.29M Sell
46,648
-7,535
-14% -$209K 0.79% 45
2023
Q4
$1.56M Buy
+54,183
New +$1.64M 0.85% 12
2022
Q1
Sell
-47,631
Closed -$2.6M 703
2021
Q4
$2.6M Sell
47,631
-6,260
-12% -$310K 0.46% 74
2021
Q3
$2.22M Buy
+53,891
New +$2.39M 0.63% 43
2021
Q2
Sell
-76,348
Closed -$2.75M 647
2021
Q1
$2.75M Sell
76,348
-44,653
-37% -$1.59M 0.55% 40
2020
Q4
$4.51M Buy
121,001
+103,715
+600% +$3.8M 0.94% 8
2020
Q3
$604K Buy
+17,286
New +$606K 0.23% 146
2020
Q2
Sell
-11,699
Closed -$374K 505
2020
Q1
$374K Sell
11,699
-11,666
-50% -$398K 0.1% 139
2019
Q4
$866K Buy
+23,365
New +$832K 0.23% 151
2019
Q1
Sell
-25,296
Closed -$983K 430
2018
Q4
$983K Buy
+25,296
New +$1.05M 0.88% 25
2016
Q4
Sell
-13,900
Closed -$446K 231
2016
Q3
$446K Sell
13,900
-21,952
-61% -$734K 1.32% 20
2016
Q2
$1.2M Buy
+35,852
New +$1.14M 0.53% 59
2016
Q1
Sell
-13,280
Closed -$407K 266
2015
Q4
$407K Buy
+13,280
New +$418K 0.42% 90

Other funds holding PFE

Sciencast Management's PFE Position: Q2 2026 in Review

Sciencast Management reduced its Pfizer (PFE) stake by 90% in Q2 2026, selling an estimated $4.76M and leaving 21,230 shares worth $511K. The position accounts for 0.11% of the portfolio, ranked #187.

Sciencast Management first reported a position in PFE in Q4 2015 and has held it in 17 quarters since. The position peaked at $5.71M in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Sciencast Management held 21,230 shares of Pfizer worth $511K as of Q2 2026.
  • Sciencast Management sold 182,029 Pfizer shares in Q2 2026, an estimated $4.76M.
  • Pfizer made up 0.11% of Sciencast Management's portfolio in Q2 2026, its #187 holding.
  • Sciencast Management first reported a position in Pfizer in Q4 2015 and has held it in 17 quarters since.
  • Sciencast Management's Pfizer position peaked at $5.71M in Q1 2026.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Sciencast Management's 13F filing for Q2 2026, filed 28 Jul 2026.